Clayton Crolius insider trades: DNA X (SONM) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Clayton reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 23, 2025 | SONM | ↓ Sell | 11,634 | $1.45 | $17K | Direct | Apr 25, 2025 (2d) |
| Sep 15, 2023 | SONM | ↑ Buy | 86,700 | $0.68 | $59K | Direct | Sep 18, 2023 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Clayton Crolius's insider trades
Clayton Crolius is Chief Financial Officer at DNA X (SONM). Since Sep 15, 2023, Clayton has reported 1 open-market purchase worth $59K and 1 sale worth $17K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (5 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SONM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.